In liver advanced diseases, the liver’s capability to eliminate toxins and metabolites is sharp decline, endotoxemia suffering from damage to the intestinal mucosal barrier would lead to an increase in serum concentrations of PCT [19]. The gene discussed is CALCA; the disease is serum lipopolysaccharide activity.